SCHEMBL1199040

SCHEMBL1199040

Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)C2CCNCC2)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 20/20 1.00
CX3CR1 P49238 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1197995 0.94 CXCR2 (1.00) CXCR2CX3CR1
SCHEMBL12843897 0.94 CXCR2 (1.00) CXCR2CX3CR1
SCHEMBL1199063 0.90 CXCR2 (1.00) CXCR2
SCHEMBL1199015 0.90 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL29537761 0.89 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL1198688 0.89 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL1199232 0.89 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL12662221 0.89 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL29815122 0.89 CXCR2 (1.00) CXCR2CX3CR1
Danirixin SCHEMBL9959547 0.89 CXCR2 (1.00) CXCR2CX3CR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2009992-B1 IL-8 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2012-06-27 EP claimed
US-20110059937-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION 2011-03-10 US claimed
US-20090093451-A1 IL-8 Receptor Antagonists SMITHKLINE BEECHAM CORPORATION (US) 2009-04-09 US claimed
EP-2009992-A2 IL-8 RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2009-01-07 EP claimed
WO-2007124424-A2 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-11-01 WO claimed
EP-2009992-B1 IL-8 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2012-06-27 EP disclosed
US-20110105563-A1 IL-8 RECEPTOR ANTAGONISTS BUSCH-PETERSEN JAKOB 2011-05-05 US disclosed
US-20110105563-A1 IL-8 RECEPTOR ANTAGONISTS BUSCH-PETERSEN JAKOB 2011-05-05 US disclosed
US-20110059937-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION 2011-03-10 US disclosed
US-20110059937-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION 2011-03-10 US disclosed
US-7893089-B2 IL-8 receptor antagonists GlaxoSmithKline, LLC (US) 2011-02-22 US disclosed
US-7893089-B2 IL-8 receptor antagonists GlaxoSmithKline, LLC (US) 2011-02-22 US disclosed
US-20090093451-A1 IL-8 Receptor Antagonists SMITHKLINE BEECHAM CORPORATION (US) 2009-04-09 US disclosed
US-20090093451-A1 IL-8 Receptor Antagonists SMITHKLINE BEECHAM CORPORATION (US) 2009-04-09 US disclosed
EP-2009992-A2 IL-8 RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2009-01-07 EP disclosed
WO-2007124424-A2 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-11-01 WO disclosed
WO-2007124424-A2 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2007-11-01 WO disclosed
US-20070249672-A1 IL-8 Receptor Antagonists GLAXOSMITHKLINE LLC 2007-10-25 US disclosed
US-20070249672-A1 IL-8 Receptor Antagonists GLAXOSMITHKLINE LLC 2007-10-25 US disclosed
US-20070249672-A1 IL-8 Receptor Antagonists GLAXOSMITHKLINE LLC 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105563-A1 IL-8 RECEPTOR ANTAGONISTS CXCL8, CCR8, IL1RN CXCR2 12/4885CX3CR1 33/4885
US-20070249672-A1 IL-8 Receptor Antagonists CXCL8, CCR8, IL1RN CXCR2 12/4885CX3CR1 33/4885
US-20110059937-A1 IL-8 RECEPTOR ANTAGONISTS CXCL8, CCR8, IL1RN CXCR2 12/4885CX3CR1 33/4885
US-20090093451-A1 IL-8 Receptor Antagonists CXCL8, CCR8, IL1RN CXCR2 12/4885CX3CR1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.